About this episode
In The Tox Talks we feature expert injectors with significant experience using botulinum toxins. We explore their experience with particular brands, how their techniques have evolved and the subtle nuances of getting the best out of toxins.
In Chapter 8, Birmingham cosmetic physician Dr David Eccleston joins us to talk about one of the newest toxin brands, Nuceiva (prabotulinumtoxinA). Made by Evolus and known as Jeuveau in the USA, Nuceiva was launching in Australia the week this episode was released.
We cover David's early Botox days and his tailored approach to toxins, UK training and regulation, KOLs and conflicts of interest, the longer-lasting toxin debate, toxin science and spread, freeze versus vacuum drying, packaging and reconstitution, preserved saline myths, consent when switching brands, technique and dosing nuances, pricing, resistance, aftercare and the future of toxins.
What you'll learn
- What Nuceiva is and how it is made
- Freeze drying versus vacuum drying
- Reconstitution and preserved saline myths
- Consent and disclosure when switching toxin brands
- Technique, dosing and dilution nuances
- The future of botulinum toxins
Topics
- The Tox Talks
- Botulinum toxin
- Nuceiva
- Jeuveau
- Evolus
- Toxin brands
- UK
Full transcript
The full transcript for this episode is coming soon.